Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

Mortality Outcomes by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

(2022) Cheng Han Ng et al.   Clinical Gastroenterology and Hepatology

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

(2022) Kenneth Cusi et al.   Endocrine Practice

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

(2022) Darren Jun Hao Tan et al.   LANCET ONCOLOGY

NAFLD versus MAFLD: Prevalence, Outcomes and Implications of a Change in Name

(2022) Cheng Han Ng et al.   Clinical and Molecular Hepatology

Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis

(2022) Ansel Tang et al.   Clinical Gastroenterology and Hepatology

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

(2022) Mohammed Eslam et al.   Nature Reviews Gastroenterology & Hepatology

What's in a disease like non‐alcoholic fatty liver disease—East versus West?

(2022) Yock Young Dan   JGH Open

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

A clinical overview of non‐alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications—What the non‐specialist needs to know

(2021) Mark D. Muthiah et al.   DIABETES OBESITY & METABOLISM

An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD

(2021) Grace En Hui Lim et al.   Clinical Gastroenterology and Hepatology

Global burden of NAFLD and chronic liver disease among adolescents and young adults

(2021) James M. Paik et al.   HEPATOLOGY

MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis

(2021) Mazen Noureddin et al.   JOURNAL OF HEPATOLOGY

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

(2020) Philip N Newsome et al.   Lancet Gastroenterology & Hepatology

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

(2020) Qing Ye et al.   Lancet Gastroenterology & Hepatology

Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

(2020) Feng‐Bin Lu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Meta-analysis of Proportions Using Generalized Linear Mixed Models

(2020) Lifeng Lin et al.   EPIDEMIOLOGY

MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis

(2020) Jinho Jung et al.   GUT

Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

(2020) Cheng Peng et al.   Frontiers in Pharmacology

Genetic and epigenetic factors determining NAFLD risk

(2020) Wenke Jonas et al.   Molecular Metabolism

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease

(2019) Krisztina Szanto et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Past, present and future perspectives in nonalcoholic fatty liver disease

(2019) Arun J. Sanyal   Nature Reviews Gastroenterology & Hepatology

Seriously misleading results using inverse of Freeman‐Tukey double arcsine transformation in meta‐analysis of single proportions

(2019) Guido Schwarzer et al.   Research Synthesis Methods

The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis

(2019) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease

(2019) Fabio Nascimbeni et al.   JOURNAL OF HEPATOLOGY

Fixed and random effects models: making an informed choice

(2018) Andrew Bell et al.   QUALITY & QUANTITY

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease

(2017) Raj Vuppalanchi et al.   HEPATOLOGY

Current and future pharmacological therapies for NAFLD/NASH

(2017) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance

(2015) Per Stål   WORLD JOURNAL OF GASTROENTEROLOGY

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

(2015) Xiang Wan et al.   BMC Medical Research Methodology

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

(2014) L. Fedchuk et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias

(2014) James P. Hunter et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal

(2012) Mariana V. Machado et al.   JOURNAL OF HEPATOLOGY

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

(2011) Robert P. Myers et al.   HEPATOLOGY

Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients

(2010) Victor De Lédinghen et al.   LIVER INTERNATIONAL

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Undue reliance on I 2 in assessing heterogeneity may mislead

(2008) Gerta Rücker et al.   BMC Medical Research Methodology